0001104659-20-120270.txt : 20201102 0001104659-20-120270.hdr.sgml : 20201102 20201102082708 ACCESSION NUMBER: 0001104659-20-120270 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201102 DATE AS OF CHANGE: 20201102 EFFECTIVENESS DATE: 20201102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 201279052 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 15-12G 1 tm2034687-1_1512g.htm 15-12G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number  000-12104

 

Immunomedics, Inc.

(Exact name of registrant as specified in its charter)

 

300 The American Road

Morris Plains, New Jersey 07950

(973) 605-8200

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.01 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

  Rule 12g-4(a)(1) x        
  Rule 12g-4(a)(2) o        
  Rule 12h-3(b)(1)(i) x        
  Rule 12h-3(b)(1)(ii) o        
  Rule 15d-6 o        
  Rule 15d-22(b) o        

 

Approximate number of holders of record as of the certification or notice date: one (1).

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Immunomedics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: November 2, 2020   IMMUNOMEDICS, INC.  
           
      By: /s/ Andrew Dickinson  
      Name: Andrew Dickinson  
      Title: President and Treasurer